These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15622321)

  • 1. F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.
    Bleeker-Rovers CP; van der Ven AJ; Zomer B; de Geus-Oei LF; Smits P; Corstens FH; Koopmans PP; Oyen WJ
    AIDS; 2004 Dec; 18(18):2430-2. PubMed ID: 15622321
    [No Abstract]   [Full Text] [Related]  

  • 2. Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy.
    Asensi V; Martín-Roces E; Carton JA; Collazos J; Maradona JA; Alonso A; Medina M; Aburto JM; Martínez E; Rojo C; Bustillo E; Fernández C; Arribas JM
    Clin Infect Dis; 2004 Jul; 39(2):240-7. PubMed ID: 15307034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET.
    Sathekge M; Maes A; Kgomo M; Stolz A; Ankrah A; Van de Wiele C
    Nucl Med Commun; 2010 Apr; 31(4):311-4. PubMed ID: 20145581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET/CT in patients with HIV.
    Davison JM; Subramaniam RM; Surasi DS; Cooley T; Mercier G; Peller PJ
    AJR Am J Roentgenol; 2011 Aug; 197(2):284-94. PubMed ID: 21785073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipodystrophy syndrome of patients infected by HIV receiving antiretroviral treatment].
    Viard JP
    Journ Annu Diabetol Hotel Dieu; 2003; ():111-23. PubMed ID: 12868306
    [No Abstract]   [Full Text] [Related]  

  • 6. [No improvement of lipodystrophy syndrome in an HIV-infected patient].
    Lanzafame M; Faggian F; Lattuada E; Antolini D; Concia E
    Recenti Prog Med; 2004 Jun; 95(6):312-3. PubMed ID: 15248414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG Uptake in Subcutaneous Fat Preceding Clinical Diagnosis of Human Immunodeficiency Virus-Associated Lipodystrophy.
    Caton MT; Miskin N; Hyun H
    Clin Nucl Med; 2018 Dec; 43(12):e475-e476. PubMed ID: 30325831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Award of the 2003 AIDS Prize. Why doesn HAART therapy induce lipodystrophy in HIV positive patients?].
    HNO; 2003 Jul; 51(7):543. PubMed ID: 12916494
    [No Abstract]   [Full Text] [Related]  

  • 9. Highly active antiretroviral therapy alone is an effective treatment for lymphadenopathic kaposi sarcoma demonstrated by a clinical and F-18 FDG positron emission tomography/computed tomography response.
    Mankia SK; Miller RF; Edwards SG; Ramsay A; Lee SM
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):309-11. PubMed ID: 22449790
    [No Abstract]   [Full Text] [Related]  

  • 10. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
    Brust D; Polis M; Davey R; Hahn B; Bacharach S; Whatley M; Fauci AS; Carrasquillo JA
    AIDS; 2006 Apr; 20(7):985-93. PubMed ID: 16603850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Criteria for AIDS-prices 2003. Why does HAART therapy in HIV patients cause fat catabolism?].
    Urologe A; 2003 Sep; 42(9):1254. PubMed ID: 14619845
    [No Abstract]   [Full Text] [Related]  

  • 13. High FDG uptake on FDG-PET scan in HIV-1 infected patient with advanced disease.
    Belkhir L; Jonckheere S; Lhommel R; Vandercam B; Yombi JC
    Acta Clin Belg; 2011; 66(6):419-21. PubMed ID: 22338303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
    Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.
    Brust D; Polis M; Davey R; Hahn B; Bacharach S; Whatley M; Fauci AS; Carrasquillo JA
    AIDS; 2006 Feb; 20(4):495-503. PubMed ID: 16470113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy.
    Calmy A; Hirschel B; Hans D; Karsegard VL; Meier CA
    AIDS; 2003 Mar; 17(5):770-2. PubMed ID: 12646807
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer mimicked on sonography: lipomastia in an HIV-positive man undergoing antiretroviral therapy.
    Busch JM; Pantanowitz L; Kornguth PJ
    AJR Am J Roentgenol; 2003 Jul; 181(1):187-9. PubMed ID: 12818856
    [No Abstract]   [Full Text] [Related]  

  • 18. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
    Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
    HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones in the treatment of HIV/HAART-associated lipodystrophy syndrome.
    Edgeworth A; Treacy MP; Hurst TP
    AIDS Rev; 2013; 15(3):171-80. PubMed ID: 24002201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.
    Lee B; Aurpibul L; Sirisanthana V; Mangklabruks A; Sirisanthana T; Puthanakit T
    HIV Med; 2009 Feb; 10(2):72-8. PubMed ID: 19018877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.